Enhanced topical delivery of tacrolimus by a carbomer hydrogel formulation with transcutol P

被引：31

作者：

Lee, Sang Gon ^{[1
]}

Kang, Jong Bu ^{[1
]}

Kim, Sung Rae ^{[1
]}

Kim, Chae Jin ^{[1
]}

Yeom, Dong Woo ^{[1
]}

Yoon, Ho Yub ^{[1
]}

Kwak, Seong Shin ^{[1
]}

Choi, Young Wook ^{[1
]}

机构：

[1] Chung Ang Univ, Coll Pharm, 221 Heuksuk Dong, Seoul 156756, South Korea

来源：

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 2016年 / 42卷 / 10期

基金：

新加坡国家研究基金会;

关键词：

Carbomer gel; tacrolimus; topical delivery; transcutol P; skin permeation; TRANSDERMAL DELIVERY; IN-VITRO; ATOPIC-DERMATITIS; PERCUTANEOUS PENETRATION; SKIN PERMEABILITY; DERMAL DELIVERY; DRUG-DELIVERY; RAT SKIN; PERMEATION; MICROEMULSION;

D O I：

10.3109/03639045.2016.1160107

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Tacrolimus (TAC), a non-steroidal anti-inflammatory and immunosuppressive agent, is used for the treatment of atopic dermatitis (AD) and skin immune diseases. TAC-loaded topical hydrogel formulations composed of carbomer, carnosine, transcutol P (diethylene glycol monoethyl ether) and humectant were prepared. For comparison, TAC-loaded topical cream-type formulations were also prepared and commercially available TAC ointment was used as a reference. A drug release study in vitro revealed that the total amount of TAC released from hydrogels over 24 h was approximately 30 times greater than that for the reference formulation. Compared to the reference ointment and creams, carbomer gel formulations showed higher skin permeation and retention of TAC (significantly different at p<0.05), especially those with more than 10% of transcutol P. Therefore, carbomer gel formulations with sufficient levels of transcutol P are good candidates for skin delivery of TAC and have potential as therapeutic agents for the treatment of AD or immune skin disorders.

引用

页码：1636 / 1642

页数：7

共 40 条

[1] Percutaneous absorption of drugs used in atopic eczema:: pimecrolimus permeates less through skin than corticosteroids and tacrolimus [J].

Billich, A ;

Aschauer, H ;

Aszódi, A ;

Stuetz, A .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 269 (01) :29-35

[2] Glycerol and urea can be used to increase skin permeability in reduced hydration conditions [J].

Bjorklund, Sebastian ;

Engblom, Johan ;

Thuresson, Krister ;

Sparr, Emma .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 (05) :638-645

[3] Development of topical hydrogels of terbinafine hydrochloride and evaluation of their antifungal activity [J].

Celebi, Nevin ;

Ermis, Seda ;

Ozkan, Semiha .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (04) :631-639

[4] Tacrolimus ointment: A review of its therapeutic potential as a topical therapy in atopic dermatitis [J].

Cheer S.M. ;

Plosker G.L. .

American Journal of Clinical Dermatology, 2001, 2 (6) :389-406

[5] Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration [J].

Chen, Huabing ;

Mou, Dongsheng ;

Du, Danrong ;

Chang, Xueling ;

Zhu, Dandan ;

Liu, Jie ;

Xu, Huibi ;

Yang, Xiangliang .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 341 (1-2) :78-84

[6]

Choi Woo Sik, 2010, Journal of Pharmaceutical Investigation, V40, P373, DOI 10.4333/KPS.2010.40.6.373

[7] Effect of methyl cellulose on gelation behavior and drug release from poloxamer based ophthalmic formulations [J].

Dewan, Mitali ;

Bhowmick, Biplab ;

Sarkar, Gunjan ;

Rana, Dipak ;

Bain, Mrinal Kanti ;

Bhowmik, Manas ;

Chattopadhyay, Dipankar .

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2015, 72 :706-710

[8] Evaluation of the transepidermal permeation of diethylene glycol monoethyl ether and skin water loss [J].

GanemQuintanar, A ;

Lafforgue, C ;

FalsonRieg, F ;

Buri, P .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 147 (02) :165-171

[9]

GOTO T, 1987, TRANSPLANT P, V19, P4

[10]

Güngör S, 2004, PHARMAZIE, V59, P39

← 1 2 3 4 →